Publication:
Atypical course of COVID-19 in patient with Bruton agammaglobulinemia

Simple item page
dc.contributor.authorMilošević, Ivana (58456808200)
dc.contributor.authorJovanović, Jaroslava (57220948637)
dc.contributor.authorStevanović, Olja (57201195181)
dc.date.accessioned2025-07-02T12:04:16Z
dc.date.available2025-07-02T12:04:16Z
dc.date.issued2020
dc.description.abstractWe present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor. © 2020 Journal of Infection in Developing Countries. All rights reserved.
dc.identifier.urihttps://doi.org/10.3855/jidc.13840
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85097916070&doi=10.3855%2fjidc.13840&partnerID=40&md5=63f87e25acf571249b4e7a78e788c44c
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/12373
dc.subjectAgammaglobulinemia
dc.subjectConvalescent plasma
dc.subjectCOVID-19
dc.subjectIL-6 inhibitor
dc.titleAtypical course of COVID-19 in patient with Bruton agammaglobulinemia
dspace.entity.typePublication

Files

Collections

Publikacije / Publications